{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:19:55Z","timestamp":1777767595382,"version":"3.51.4"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000882","name":"Brain Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12NS098482"],"award-info":[{"award-number":["K12NS098482"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HD117430"],"award-info":[{"award-number":["R21HD117430"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clp.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T13:23:02Z","timestamp":1743168182000},"page":"289-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel Approaches to the Treatment of Preterm White Matter Injury through Targeting Remyelination"],"prefix":"10.1016","volume":"52","author":[{"given":"Bridget E.L.","family":"Ostrem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Gano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clp.2025.02.005_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2021.151469","article-title":"The dimensions of white matter injury in preterm neonates","volume":"45","author":"Guillot","year":"2021","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.clp.2025.02.005_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pediatrneurol.2023.08.001","article-title":"Acquired brain injuries across the perinatal spectrum: pathophysiology and emerging therapies","volume":"148","author":"Russ","year":"2023","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat Med"},{"issue":"7555","key":"10.1016\/j.clp.2025.02.005_bib4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature14335","article-title":"Drug-based modulation of endogenous stem cells promotes functional remyelination in\u00a0vivo","volume":"522","author":"Najm","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1087057114559490","article-title":"High-content phenotypic screening and triaging strategy to identify small molecules driving oligodendrocyte progenitor cell differentiation","volume":"20","author":"Peppard","year":"2015","journal-title":"J\u00a0Biomol Screen"},{"key":"10.1016\/j.clp.2025.02.005_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12868-016-0250-2","article-title":"Development of a central nervous system axonal myelination assay for high throughput screening","volume":"17","author":"Lariosa-Willingham","year":"2016","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.clp.2025.02.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103276","article-title":"Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence","volume":"65","author":"Manousi","year":"2021","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib8","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/acschembio.2c00330","article-title":"Enhancers of human and rodent oligodendrocyte formation predominantly induce cholesterol precursor accumulation","volume":"17","author":"Sax","year":"2022","journal-title":"ACS Chem Biol"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106156","article-title":"High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(20)30140-X","article-title":"Remyelination in multiple sclerosis: from basic science to clinical translation","volume":"19","author":"Lubetzki","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clp.2025.02.005_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1207007","article-title":"Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration","volume":"16","author":"Packer","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.clp.2025.02.005_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2019.02.016","article-title":"Dysmaturation of premature brain: importance, cellular mechanisms, and potential interventions","volume":"95","author":"Volpe","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib13","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neuron.2021.02.003","article-title":"Building a (w)rapport between neurons and oligodendroglia: reciprocal interactions underlying adaptive myelination","volume":"109","author":"Pease-Raissi","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.clp.2025.02.005_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.05.005.2009","article-title":"Oligodendrocyte development and the onset of myelination in the human fetal brain","volume":"3","author":"Jakovcevski","year":"2009","journal-title":"Front Neuroanat"},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","article-title":"Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury","volume":"21","author":"Back","year":"2001","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/glia.23256","article-title":"Origin and dynamics of oligodendrocytes in the developing brain: implications for perinatal white matter injury","volume":"66","author":"van Tilborg","year":"2018","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cercor\/bhu178","article-title":"Development of the cell population in the brain white matter of young children","volume":"26","author":"Sigaard","year":"2016","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.clp.2025.02.005_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fneur.2018.00159","article-title":"Lymphocytes contribute to the pathophysiology of neonatal brain injury","volume":"9","author":"Nazmi","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.clp.2025.02.005_bib19","series-title":"Neonatal care. In-tech","first-page":"87","article-title":"Parenchymatous brain injury in premature infants: intraventricular hemorrhage and periventricular leukomalacia","author":"Barr\u00eda","year":"2012"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1523\/JNEUROSCI.22-02-00455.2002","article-title":"Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia","volume":"22","author":"Back","year":"2002","journal-title":"J\u00a0Neurosci"},{"issue":"11","key":"10.1016\/j.clp.2025.02.005_bib21","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/glia.22658","article-title":"Pathophysiology of glia in perinatal white matter injury","volume":"62","author":"Back","year":"2014","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41390-020-01162-2","article-title":"Bronchopulmonary dysplasia precursors influence risk of white matter injury and adverse neurodevelopmental outcome in preterm infants","volume":"90","author":"Grelli","year":"2021","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2020.101106","article-title":"Cerebral palsy after very preterm birth - an imaging perspective","volume":"25","author":"Gano","year":"2020","journal-title":"Semin Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.clp.2025.02.005_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00234-008-0408-4","article-title":"Comparing brain white matter on sequential cranial ultrasound and MRI in very preterm infants","volume":"50","author":"Leijser","year":"2008","journal-title":"Neuroradiology"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpeds.2014.09.009","article-title":"Diminished white matter injury over time in a cohort of premature newborns","volume":"166","author":"Gano","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2025.02.005_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpeds.2021.06.014","article-title":"Neuroimaging of the preterm brain: review and recommendations","volume":"237","author":"Inder","year":"2021","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib27","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209264","article-title":"Size and location of preterm brain injury and associations with neurodevelopmental outcomes","volume":"102","author":"Selvanathan","year":"2024","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.clp.2025.02.005_bib28","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1212\/WNL.0000000000008172","article-title":"Predicting developmental outcomes in preterm infants: a simple white matter injury imaging rule","volume":"93","author":"Cayam-Rand","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clp.2025.02.005_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13643-015-0058-7","article-title":"Predicting developmental outcomes in premature infants by term equivalent MRI: systematic review and meta-analysis","volume":"4","author":"Van\u2019t Hooft","year":"2015","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41390-023-02895-6","article-title":"Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series)","volume":"95","author":"Molloy","year":"2024","journal-title":"Pediatr Res"},{"issue":"1\u20131","key":"10.1016\/j.clp.2025.02.005_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/pr.2017.227","article-title":"Effects of early nutrition and growth on brain volumes, white matter microstructure, and neurodevelopmental outcome in preterm newborns","volume":"83","author":"Coviello","year":"2018","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.22267","article-title":"Procedural pain and brain development in premature newborns","volume":"71","author":"Brummelte","year":"2012","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1891\/0730-0832.35.2.73","article-title":"White matter injury in premature newborns","volume":"35","author":"Gano","year":"2016","journal-title":"Neonatal Netw"},{"issue":"7","key":"10.1016\/j.clp.2025.02.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2021.151467","article-title":"Preterm neuroimaging: a fulcrum to advocate for earlier intervention","volume":"45","author":"Gano","year":"2021","journal-title":"Semin Perinatol"},{"issue":"1\u20132","key":"10.1016\/j.clp.2025.02.005_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2004.11.036","article-title":"Erythropoietin treatment improves neurological functional recovery in EAE mice","volume":"1034","author":"Zhang","year":"2005","journal-title":"Brain Res"},{"issue":"1\u20134","key":"10.1016\/j.clp.2025.02.005_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000459620","article-title":"Optimizing the dose of erythropoietin required to prevent acute ventilation-induced cerebral white matter injury in preterm lambs","volume":"39","author":"Chan","year":"2017","journal-title":"Dev Neurosci"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/jcbfm.2013.174","article-title":"Partial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep","volume":"34","author":"Drury","year":"2014","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.clp.2025.02.005_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fncel.2017.00296","article-title":"The beneficial effects of melatonin administration following hypoxia-ischemia in preterm fetal sheep","volume":"11","author":"Yawno","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0271678X17729954","article-title":"Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep","volume":"39","author":"van den Heuij","year":"2019","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib40","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/antiox12081630","article-title":"Melatonin as a therapy for preterm brain injury: what is the evidence?","volume":"12","author":"H\u00e4usler","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.clp.2025.02.005_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114461","article-title":"Therapeutic potential of stem cells for preterm infant brain damage: can we move from the heterogeneity of preclinical and clinical studies to established therapeutics?","volume":"186","author":"Passera","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.clp.2025.02.005_bib42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.21008","article-title":"Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury","volume":"60","author":"Back","year":"2006","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/13524585211008760","article-title":"Current status of neuroprotective and neuroregenerative strategies in multiple sclerosis: a systematic review","volume":"28","author":"Allanach","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.clp.2025.02.005_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2009.10.054","article-title":"Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by Guinea pig spinal cord homogenates in Wistar rats","volume":"1309","author":"Chen","year":"2010","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Zhang","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clp.2025.02.005_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fphar.2019.00147","article-title":"Melatonin therapy modulates cerebral metabolism and enhances remyelination by increasing PDK4 in a mouse model of multiple sclerosis","volume":"10","author":"Ghareghani","year":"2019","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib47","doi-asserted-by":"crossref","first-page":"e2223","DOI":"10.1038\/cddis.2016.130","article-title":"Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model","volume":"7","author":"Cruz-Martinez","year":"2016","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.18502\/jovr.v14i3.4786","article-title":"Visual outcomes of adding erythropoietin to methylprednisolone for treatment of retrobulbar optic neuritis","volume":"14","author":"Soltan Sanjari","year":"2019","journal-title":"J\u00a0Ophthalmic Vis Res"},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib49","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200067","article-title":"Treatment with erythropoietin for patients with optic neuritis: long-term follow-up","volume":"10","author":"K\u00fcchlin","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.clp.2025.02.005_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105681","article-title":"Neurological efficacy and safety of mesenchymal stem cells (MSCs) therapy in people with multiple sclerosis (pwMS): an updated systematic review and meta-analysis","volume":"87","author":"Vaheb","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A\u00a0randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.clp.2025.02.005_bib52","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4317","article-title":"Prophylactic early erythropoietin for neuroprotection in preterm infants: a meta-analysis","volume":"139","author":"Fischer","year":"2017","journal-title":"Pediatrics"},{"issue":"19","key":"10.1016\/j.clp.2025.02.005_bib54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2016.5504","article-title":"Effect of early prophylactic high-dose recombinant human erythropoietin in very preterm infants on neurodevelopmental outcome at 2 years: a randomized clinical trial","volume":"315","author":"Natalucci","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2025.02.005_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103605","article-title":"Early biomarkers of hypoxia and inflammation and two-year neurodevelopmental outcomes in the preterm erythropoietin neuroprotection (PENUT) trial","volume":"72","author":"Wood","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-079X.2005.00251.x","article-title":"Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment","volume":"39","author":"Gitto","year":"2005","journal-title":"J\u00a0Pineal Res"},{"issue":"6","key":"10.1016\/j.clp.2025.02.005_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41372-024-01939-x","article-title":"Caffeine for apnea and prevention of neurodevelopmental impairment in preterm infants: systematic review and meta-analysis","volume":"44","author":"Oliphant","year":"2024","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.clp.2025.02.005_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2020.103495","article-title":"Early application of caffeine improves white matter development in very preterm infants","volume":"281","author":"Liu","year":"2020","journal-title":"Respir Physiol Neurobiol"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","article-title":"The changing demographic pattern of multiple sclerosis epidemiology","volume":"9","author":"Koch-Henriksen","year":"2010","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.clp.2025.02.005_bib61","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/1352458517721355","article-title":"The Xenopus tadpole: an in\u00a0vivo model to screen drugs favoring remyelination","volume":"24","author":"Mannioui","year":"2018","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/brain\/awx312","article-title":"Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury","volume":"141","author":"Cree","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.neuron.2018.07.017","article-title":"Enhancing oligodendrocyte myelination rescues synaptic loss and improves functional recovery after chronic hypoxia","volume":"99","author":"Wang","year":"2018","journal-title":"Neuron"},{"issue":"10111","key":"10.1016\/j.clp.2025.02.005_bib64","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clp.2025.02.005_bib65","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","article-title":"Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors","volume":"39","author":"Rankin","year":"2019","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22593","article-title":"Olesoxime accelerates myelination and promotes repair in models of demyelination","volume":"71","author":"Magalon","year":"2012","journal-title":"Ann Neurol"},{"issue":"14_supplement","key":"10.1016\/j.clp.2025.02.005_bib67","doi-asserted-by":"crossref","first-page":"P7","DOI":"10.1212\/WNL.84.14_supplement.P7.282","article-title":"Results of a Phase 1b study to confirm safety and tolerability of olesoxime in multiple sclerosis patients (P7.282)","volume":"84","author":"Pelletier","year":"2015","journal-title":"Neurology"},{"issue":"52","key":"10.1016\/j.clp.2025.02.005_bib68","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1523\/JNEUROSCI.4453-08.2008","article-title":"Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging","volume":"28","author":"Harsan","year":"2008","journal-title":"J\u00a0Neurosci"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib69","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11011-015-9781-y","article-title":"Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice","volume":"31","author":"Zendedel","year":"2016","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.clp.2025.02.005_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.clp.2025.02.005_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00492","article-title":"Quetiapine inhibits microglial activation by neutralizing abnormal STIM1-mediated intercellular calcium homeostasis and promotes myelin repair in a cuprizone-induced mouse model of demyelination","volume":"9","author":"Wang","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.clp.2025.02.005_bib72","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/pr.2018.45","article-title":"Clemastine effects in rat models of a myelination disorder","volume":"83","author":"Turski","year":"2018","journal-title":"Pediatr Res"},{"issue":"7471","key":"10.1016\/j.clp.2025.02.005_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12647","article-title":"A\u00a0regenerative approach to the treatment of multiple sclerosis","volume":"502","author":"Deshmukh","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clp.2025.02.005_bib74","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.3389\/fimmu.2018.02784","article-title":"Tuftsin combines with remyelinating therapy and improves outcomes in models of CNS demyelinating disease","volume":"9","author":"Thompson","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12264-015-1555-3","article-title":"Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination","volume":"31","author":"Li","year":"2015","journal-title":"Neurosci Bull"},{"issue":"9","key":"10.1016\/j.clp.2025.02.005_bib76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0192-0561(00)00029-1","article-title":"Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation","volume":"22","author":"Dimitriadou","year":"2000","journal-title":"Int J Immunopharm"},{"issue":"12","key":"10.1016\/j.clp.2025.02.005_bib77","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/nm1668","article-title":"Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system","volume":"13","author":"Friese","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.clp.2025.02.005_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/srep31599","article-title":"Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system","volume":"6","author":"Gonzalez","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clp.2025.02.005_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1254303","article-title":"The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation","volume":"17","author":"Narine","year":"2023","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"10.1016\/j.clp.2025.02.005_bib80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cns.12154","article-title":"Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair","volume":"19","author":"Zhornitsky","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"20","key":"10.1016\/j.clp.2025.02.005_bib81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: results from the ReBUILD trial","volume":"120","author":"Caverzasi","year":"2023","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib82","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/039463200501800421","article-title":"A\u00a0pilot, open label, clinical trial using hydroxyzine in multiple sclerosis","volume":"18","author":"Logothetis","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib83","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1474-4422(19)30485-5","article-title":"Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial","volume":"19","author":"Chataway","year":"2020","journal-title":"Lancet Neurol"},{"issue":"Pt 1","key":"10.1016\/j.clp.2025.02.005_bib84","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/brain\/aws325","article-title":"Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride","volume":"136","author":"Arun","year":"2013","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.clp.2025.02.005_bib85","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib86","first-page":"1124","article-title":"The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial","volume":"271","author":"Abdelgaied","year":"2024","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.clp.2025.02.005_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102015","article-title":"Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: a dose-ranging study with assessment of reliability of visual outcomes","volume":"41","author":"Wooliscroft","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/j.clp.2025.02.005_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1362629","article-title":"A\u00a0metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial","volume":"15","author":"De Keersmaecker","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejpn.2006.11.009","article-title":"T3 replacement does not prevent excitotoxic cell death but reduces developmental neuronal apoptosis in newborn mice","volume":"11","author":"S\u00e1rk\u00f6zy","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.clp.2025.02.005_bib90","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1161\/STROKEAHA.113.001552","article-title":"Thyroxin treatment protects against white matter injury in the immature brain via brain-derived neurotrophic factor","volume":"44","author":"Hung","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.clp.2025.02.005_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-024-03326-w","article-title":"Minimum effective dose of clemastine in a mouse model of preterm white matter injury","author":"Odell","year":"2024","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2003.10.048","article-title":"Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats","volume":"484","author":"Feng","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.clp.2025.02.005_bib93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1203\/01.pdr.0000196805.68082.22","article-title":"N-methyl-isobutyl-amiloride ameliorates brain injury when commenced before hypoxia ischemia in neonatal mice","volume":"59","author":"Kendall","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2025.02.005_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2020.100119","article-title":"Subacute metformin treatment reduces inflammation and improves functional outcome following neonatal hypoxia ischemia","volume":"7","author":"Livingston","year":"2020","journal-title":"Brain, Behavior, & Immunity - Health"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5863\/1551-6776-21.1.36","article-title":"Medication repurposing in pediatric patients: teaching old drugs new tricks","volume":"21","author":"Rumore","year":"2016","journal-title":"J\u00a0Pediatr Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.clp.2025.02.005_bib96","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bcp.12753","article-title":"Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics","volume":"81","author":"Donovan","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clp.2025.02.005_bib97","unstructured":"U.S. Food and Drug Administration. Considerations for long-term clinical neurodevelopmental safety studies in neonatal product development: guidance for industry. 2023."},{"key":"10.1016\/j.clp.2025.02.005_bib98","unstructured":"U.S. Food and Drug Administration. General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products. Published online July 2022."},{"issue":"4","key":"10.1016\/j.clp.2025.02.005_bib99","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/bdrb.20328","article-title":"The value of juvenile animal studies \u201cWhat have we learned from preclinical juvenile toxicity studies? II.\u201d","volume":"92","author":"Bailey","year":"2011","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.clp.2025.02.005_bib100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/01926233231225239","article-title":"Toxicologic pathology forum opinion: rational approaches to expanded neurohistopathology evaluation for nonclinical general toxicity studies and juvenile animal studies","volume":"51","author":"Bolon","year":"2023","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.clp.2025.02.005_bib101","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510825000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:42:24Z","timestamp":1777477344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510825000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0095510825000077"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2025.02.005","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Approaches to the Treatment of Preterm White Matter Injury through Targeting Remyelination","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}